SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-10-022087
Filing Date
2010-03-08
Accepted
2010-03-08 16:21:34
Documents
13
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K c97445e10vk.htm 10-K 950044
2 EXHIBIT 10.36 c97445exv10w36.htm EX-10.36 7304
3 EXHIBIT 10.37 c97445exv10w37.htm EX-10.37 27710
4 EXHIBIT 10.40 c97445exv10w40.htm EX-10.40 24501
5 EXHIBIT 10.44 c97445exv10w44.htm EX-10.44 695481
6 EXHIBIT 21.1 c97445exv21w1.htm EX-21.1 797
7 EXHIBIT 23.1 c97445exv23w1.htm EX-23.1 6461
8 EXHIBIT 31.1 c97445exv31w1.htm EX-31.1 5938
9 EXHIBIT 31.2 c97445exv31w2.htm EX-31.2 5904
10 EXHIBIT 32.1 c97445exv32w1.htm EX-32.1 2506
11 EXHIBIT 32.2 c97445exv32w2.htm EX-32.2 2495
12 GRAPHIC c97445c9744501.gif GRAPHIC 9866
13 GRAPHIC c97445c9744502.gif GRAPHIC 17093
  Complete submission text file 0000950123-10-022087.txt   1768097
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 033-80623 | Film No.: 10663998
SIC: 2835 In Vitro & In Vivo Diagnostic Substances